Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: NOVARTIS PHARMACEUTICALS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-10-01 to 2026-09-30
Current total value of award: $3175975.6
Description: LUTATHERA AND PLUVICTO